Pesampator

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NamePesampator
Drug Alias NamePF-4958242PF-04958242BIIB-104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate receptor ionotropic AMPA modulators
TargetsGlutamate receptor ionotropic AMPA
Therapy Area/IndicationsSchizophreniaCognition DisordersHearing Loss, Sensorineural +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeGermany +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiogen Inc
Inactive CompaniesN/A
Active IndicationsCognition Disorders
Inactive IndicationsSchizophreniaHearing Loss, SensorineuralSpondylitis, Ankylosing

Other Information

ATC CodeN/A
Related LinksN/A